Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Yu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8578-7268; OpenAlex author ID A5100345660. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Development and preliminary evaluation of a Neuman Systems Model-based protocol for postoperative delirium prevention in patients undergoing pancreatic cancer … First author DOI 10.1097/md.0000000000050172↗
  2. Deep learning-based CT model for non-invasive prediction of tertiary lymphoid structures in pancreatic cancer: a multicenter study with prospective validation … Co-author DOI 10.1136/jitc-2026-015705↗
  3. Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer. First author DOI 10.1021/acs.jmedchem.1c01535↗
  4. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5172-1↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenli Xu · 1 shared paper, 2026 · strength 0.50
  2. Shujia Wang · 1 shared paper, 2026 · strength 0.50
  3. Xiaoying Li · 1 shared paper, 2026 · strength 0.30
  4. Haopeng Yu · 1 shared paper, 2026 · strength 0.30
  5. Yuqi Wang · 1 shared paper, 2026 · strength 0.30
  6. Dan Cao · 1 shared paper, 2026 · strength 0.30
  7. Yungen Xu · 1 shared paper, 2021 · strength 0.12
  8. Shu-Ping Wang · 1 shared paper, 2021 · strength 0.12
  9. Qin Sun · 1 shared paper, 2021 · strength 0.12
  10. Shihui Huang · 1 shared paper, 2021 · strength 0.12
  11. Shiqi Wu · 1 shared paper, 2021 · strength 0.12
  12. Hua Liu · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.